Abercrombie: China Noise Overshadows A Cheap Earnings Multiple

Abercrombie (ANF): China Noise Overshadows A Cheap Earnings Multiple

The Bloomberg report today that Abercrombie is exploring options for its China business - including the possibility of bringing in local partners or selling a stake - is being treated by some as a sign of strategic distress. It isn't. China accounts for a small fraction of Abercrombie's revenue. The deliberations are preliminary. And the more interesting angle is that the stock is sitting at 9.8 times trailing earnings and 5.0 times EV/EBITDA (enterprise value over earnings before interest, taxes, depreciation, and amortization - a proxy for cash-earnings power) while the core business is still growing sales, expanding margins, and generating $416 million in free cash flow.

That is a valuation reset that has outpaced whatever deterioration the China, tariff, and EMEA headwinds have actually inflicted. The stock has fallen from its 52-week high of $133 to around $109 today, down roughly 18% off the top and 13% year-to-date. The business, by contrast, is not that far off the trajectory that got the stock to $133 in the first place.

What The China Story Actually Is

Abercrombie is working with an adviser on a review of its Chinese assets. The unit could be valued at "several hundred million dollars" against a company market cap of $4.9 billion. Deliberations are preliminary and may not lead to any transaction, according to Bloomberg's sources. An Abercrombie representative declined to comment and pointed instead to a strategic review of the entire Asia-Pacific business announced in March.

The scale context matters. Asia-Pacific as a whole generated $46.5 million in the fiscal first quarter ending May 2, representing 4.2% of total revenue. China is a subset of that figure - a fraction of a fraction of the $5.0 billion in trailing-twelve-month revenue. Even at several hundred million in stake value, this is not the kind of asset overhaul that rewrites the earnings model.

This is a capital-allocation story, not a crisis story. Bringing in local partners or selling a stake in a small, struggling overseas unit is the kind of move that frees management to concentrate on what's actually producing results.

The Operating Engine Is Still Running

Here is the part investors are ignoring because the China headline is louder.

Abercrombie has posted 14 consecutive quarters of revenue growth. Fiscal fourth quarter 2025 revenue climbed 5.4% to $1.67 billion, in line with Wall Street expectations. Fiscal first quarter 2026 revenue was $1.11 billion, slightly above the $1.10 billion year-ago figure despite Middle East headwinds that reduced companywide sales growth by more than 0.5 percentage points, per CFO Robert Ball.

The margin and cash-generation profile is where the stock earned its multiple expansion earlier this year. Operating margin sits at 13.0%. Gross margin is 61.7%. Free cash flow for the trailing twelve months is $416 million on a 7.9% free cash flow margin, up from operating cash flow of $667 million after $251 million in capex. Return on invested capital is 37.7%, and return on equity is 39.0%. Those are not numbers from a company in structural decline.

EPS has been solid, too. The company beat estimates in each of the last three reported quarters: $2.50 versus $2.39 in Q3 2025, $3.68 a share versus $3.57 in Q4 2025, and $1.47 versus $1.36 in Q1 2026. Fiscal second quarter results are due on August 26, 2026, with consensus calling for $2.30 per share on $1.20 billion in revenue.

The growth rate has decelerated - full-year 2026 guidance calls for 3% to 5% revenue growth, versus higher growth in prior years - and same-store sales slowed to just 1% in the fourth quarter. That deceleration is real. Tariff uncertainty, Middle East disruption to EMEA (which accounts for 15% of revenue and fell 10% in Q1 2026), and a tougher consumer environment are all legitimate headwinds. But deceleration to low-single-digit growth is not the same as deterioration.

Valuation Has Fallen Further Than The Business

This is the core of the thesis. The stock trades at 9.8 times trailing earnings and 11.0 times forward earnings. EV/EBITDA is 5.0x. EV/sales is 0.8x. These are multiples you associate with companies in distress, not with a retailer that grew revenue for 14 straight quarters and generates nearly $420 million in annual free cash flow.

Put that in peer context. Ralph Lauren, the closest apparel peer in terms of brand positioning, trades at 24.1 times trailing earnings and 15.5 times EV/EBITDA - roughly three times Abercrombie's enterprise-value-to-EBITDA multiple. Abercrombie is priced below the company that is growing and above the one that isn't, which is exactly where it should be.

The stock's prior multiple was higher. At its 52-week high of $133, Abercrombie was trading closer to 12 times trailing earnings. The compression to 9.8x has been driven by tariff war anxiety, recession fears, EMEA weakness, and now the China headline. But none of those headwinds have destroyed the earnings base the multiple is attached to.

The balance sheet carries manageable risk. Total debt of $2.1 billion is offset by $594 million in cash. The current ratio is 144.8%, showing comfortable short-term liquidity. The company has the financial flexibility to weather near-term uncertainty without needing to raise capital at unfavorable terms.

The Catalyst Clock

The next earnings report on August 26 is the immediate inflection point. Second quarter consensus calls for $2.30 per share, well above the $1.80 to $2.00 range the company itself guided to for this quarter back in May. If Abercrombie beats that consensus number - as it has in each of the last three quarters - and reaffirms the 3% to 5% full-year revenue guidance, the stock should re-rate toward at least its prior 11x to 12x earnings multiple. That implies a price range of $120 to $130, representing roughly 10% to 19% upside from today's $109.

The China review is a secondary catalyst. If the company announces a partnership structure or stake sale that reduces overhead and generates cash, that would be a clean, positive signal of disciplined capital allocation. If it stalls or turns messy, the market impact is limited given the small revenue weight.

What Could Break This

Three risks are real:

• Tariff escalation. If tariff costs rise beyond the 0.2 percentage point hit on profitability that management currently expects for fiscal 2026, margins could take a meaningful hit. The company had originally projected a 0.7 percentage point impact before the Supreme Court struck down some reciprocal tariffs, so the risk is partially abated but not eliminated.
• EMEA and China weakness persists. If the Middle East conflict extends its disruption and China underperforms further, total revenue growth could fall below the guided 3% to 5% range. That would pressure the growth narrative and potentially the multiple.
• The tariff refund falls through. The company has applied for a tariff refund of around $100 million but has not factored it into guidance. If that refund doesn't materialize, it's a headwind that was never priced in anyway, so the risk is one-sided in the positive direction.

Verdict

Abercrombie is a buy at this level. The China headline is being used as cover to sell a stock whose valuation has reset faster than its business has deteriorated. A company growing revenue for 14 consecutive quarters, generating $416 million in free cash flow, operating at a 37.7% return on invested capital, and trading at 9.8 times earnings is not a trap - it's a mismatch.

The August 26 earnings report is the proof point. A beat and stable guidance should pull the stock back toward its prior multiple range. The risk/reward at $109, with a potential path to $120-plus on a catalyst and downside limited by the cash-generative business model, is the kind of setup that makes selling into a small China headline a costly mistake.

Rating: Buy